N-(2-(tert-butylamino)-2-oxoethyl)-N-(4-(hydroxycarbamoyl)benzyl)-3,4-dimethylbenzamide

ID: ALA4289151

PubChem CID: 145987935

Max Phase: Preclinical

Molecular Formula: C23H29N3O4

Molecular Weight: 411.50

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(C(=O)N(CC(=O)NC(C)(C)C)Cc2ccc(C(=O)NO)cc2)cc1C

Standard InChI:  InChI=1S/C23H29N3O4/c1-15-6-9-19(12-16(15)2)22(29)26(14-20(27)24-23(3,4)5)13-17-7-10-18(11-8-17)21(28)25-30/h6-12,30H,13-14H2,1-5H3,(H,24,27)(H,25,28)

Standard InChI Key:  YSKBXECDMKZLHT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 31  0  0  0  0  0  0  0  0999 V2000
    6.7425   -6.0051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7413   -6.8246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4494   -7.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1590   -6.8241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1562   -6.0015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4476   -5.5962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8674   -7.2316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8687   -8.0488    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5745   -6.8219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2828   -7.2294    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0347   -5.5967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3271   -6.0054    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6193   -5.5970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6191   -4.7798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9112   -4.3714    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3267   -4.3710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3273   -6.8226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0351   -7.2310    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9111   -3.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2032   -3.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6187   -3.1454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9044   -2.7364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6196   -7.2314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9133   -6.8192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2062   -7.2272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2060   -8.0453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9187   -8.4536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6229   -8.0431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4986   -6.8185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4989   -8.4550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  1 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 12 17  1  0
 17 18  2  0
 15 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 17 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 25 29  1  0
 26 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4289151

    ---

Associated Targets(Human)

HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC1 Tclin Histone deacetylase 1 (10854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFF (353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Histone deacetylase (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.50Molecular Weight (Monoisotopic): 411.2158AlogP: 2.98#Rotatable Bonds: 6
Polar Surface Area: 98.74Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.05CX Basic pKa: CX LogP: 2.82CX LogD: 2.81
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.50Np Likeness Score: -1.56

References

1. Diedrich D, Stenzel K, Hesping E, Antonova-Koch Y, Gebru T, Duffy S, Fisher G, Schöler A, Meister S, Kurz T, Avery VM, Winzeler EA, Held J, Andrews KT, Hansen FK..  (2018)  One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.,  158  [PMID:30245402] [10.1016/j.ejmech.2018.09.018]

Source